ORMP
Oramed Pharmaceuticals Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-26
Figures on this page computed 2026-11-08 12:40 UTC
Last close
4.13USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-26
2.5xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-034835
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-26
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-034835
- Reported in
- USD
- 10-K for 2025, filed 2026-03-26
- 10-K for 2025, filed 2026-03-26
- 10-K for 2025, filed 2026-03-26
- 10-K for 2025, filed 2026-03-26
- 10-K for 2025, filed 2026-03-26
- 10-Q for 2025, filed 2026-08-10
n/mNet marginnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-034835
- Reported in
- USD
- 10-K for 2025, filed 2026-03-26
- 10-K for 2025, filed 2026-03-26
-457.7%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-034835
- Reported in
- USD
- 10-K for 2025, filed 2026-03-26
- 10-K for 2025, filed 2026-03-26
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-034835
- Reported in
- USD
- 10-K for 2025, filed 2026-03-26
- 10-K for 2025, filed 2026-03-26
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Margins is the furthest below its sector's middle: 0.06 against 0.41 on the market's range.
- Growth-5.9%62 of 100, above its sector
- Returns on capital32.1%96 of 100, above its sector
- Margins0.7%6 of 100, below its sector
- Price2.5x58 of 100, above its sector
- Safety6.9874 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
What it sells, to whom
lens 8 of 9The filer tagged nothing for this, so there is nothing filed to draw.
Nothing is drawn in its place. The other lenses are unaffected.
This filer tagged no segment and no customer.